<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03927430</url>
  </required_header>
  <id_info>
    <org_study_id>SKC01/2019</org_study_id>
    <nct_id>NCT03927430</nct_id>
  </id_info>
  <brief_title>Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen</brief_title>
  <official_title>To Peel or Not to Peel: Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Chemnitz gGmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinikum Chemnitz gGmbH</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical outcome of patients with macular drusen and co-existing abnormalities of the
      vitreoretinal interface, who routinely undergo pars plana vitrectomy with membrane peeling,
      is evaluated. Best corrected visual acuity as well as optical coherence tomography data are
      compared at baseline and last follow up. The rate of development of choroidal
      neovascularization postoperatively is noted.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">March 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of patients with CNV</measure>
    <time_frame>last visit, in common 6 months postoperatively</time_frame>
    <description>number of patients with CNV (choroidal neovascularization) development</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BCVA</measure>
    <time_frame>last visit, in common 6 months postoperatively</time_frame>
    <description>best corrected visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of central retinal atrophy</measure>
    <time_frame>last visit, in common 6 months postoperatively</time_frame>
    <description>development of central retinal atrophy on OCT</description>
  </secondary_outcome>
  <enrollment type="Actual">40</enrollment>
  <condition>Epiretinal Membrane</condition>
  <condition>Macular Holes</condition>
  <condition>Age Related Macular Degeneration</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pars plana vitrectomy with membrane peeling</intervention_name>
    <description>23-gauge pars plana vitrectomy with peeling of the epiretinal and internal limiting membrane as well as air- or gastamponade</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        mostly elderly people, mean age 66 years, both males and females
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. participants diagnosed with ERM or FTMH and co-existing macular drusen;

          2. undergone pars plana vitrectomy with ILM and epiretinale membrane peeling;

          3. SD-OCT at the initial visit and at last follow up visit with image quality score &gt;30;

          4. no evidence of CNV on initial fluorescein angiography (FA).

        Exclusion Criteria:

          1. history of other macular disease, severe non-proliferative or proliferative diabetic
             retinopathy, other retinal vascular diseases, glaucoma, myopic retinopathy, or other
             diseases interfering with OCT images in any one of the eyes;

          2. active CNV or history of CNV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katrin Engelmann, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Klinikum Chemnitz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum Chemnitz, Ophthalmology Department</name>
      <address>
        <city>Chemnitz</city>
        <state>Saxony</state>
        <zip>09116</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 15, 2019</study_first_submitted>
  <study_first_submitted_qc>April 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2019</study_first_posted>
  <last_update_submitted>April 29, 2019</last_update_submitted>
  <last_update_submitted_qc>April 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Chemnitz gGmbH</investigator_affiliation>
    <investigator_full_name>Katrin Engelmann</investigator_full_name>
    <investigator_title>Head of Ophthalmology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
    <mesh_term>Retinal Perforations</mesh_term>
    <mesh_term>Epiretinal Membrane</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

